Kee, Anthony J.
Chagan, Jayshan
Chan, Jeng Yie
Bryce, Nicole S. http://orcid.org/0000-0001-9799-7393
Lucas, Christine A.
Zeng, Jun
Hook, Jeff
Treutlein, Herbert http://orcid.org/0000-0001-5553-5553
Laybutt, D. Ross
Stehn, Justine R.
Gunning, Peter W.
Hardeman, Edna C.
Article History
Received: 30 November 2017
Accepted: 1 March 2018
First Online: 15 March 2018
Competing Interests
: P.W.G. is on the Scientific Advisory Board of Kazia, a company which is developing anti-Tpm3.1 drugs for the treatment of cancer. P.W.G.’s laboratory receives funding Kazia to test the activity of anti-Tpm3.1 compounds. E.C.H. and P.W.G. are recipients of an Australian Department of Industry, Innovation and Science grant with Kazia to develop second generation anti-Tpm3.1 drugs.